Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akash Kalro

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Medical Journal of Australia|October 23, 2021
Progressive multifocal leukoencephalopathy: a complication of prolonged immunosuppression for plasma cell myelomaSophie C Burn, Akash Kalro
Pathology|December 5, 2016
Breakthrough fusariosis presenting initially with pyomyositisAndros Zhu, Swe Htet, Akash Kalro, et al.
Respirology Case Reports|June 7, 2021
Pulmonary AL amyloidosis and multiple myeloma presenting as cough with diffuse pulmonary opacitiesAlan Xu, Emily Lawton, Steven Smith, et al.
Ear, Nose, & Throat Journal|May 14, 2019
Sphenopalatine Artery Ligation for Life-Threatening Epistaxis in a 4-Year-Old Child With Glanzmann ThrombastheniaNayellin Reyes-Chicuellar, Neela Mouli Doddi, Akash Kalro, et al.
Respiratory Medicine Case Reports|December 19, 2018
Pulmonary AL- amyloidosis masquerading as lung malignancy in an Australian Indigenous patient with Sjogren's syndromeSubash Heraganahally, Madeline Digges, Madeleine Haygarth, et al.
Internal Medicine Journal|August 8, 2017
Bisphosphonate guidelines for treatment and prevention of myeloma bone diseaseOi Lin Lee, Noemi Horvath, Cindy Lee, et al.
Internal Medicine Journal|January 12, 2017
Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory GroupDipti Talaulikar, Constantine S Tam, Douglas Joshua, et al.
Bone Marrow Transplantation|April 29, 2021
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograftMatthew J Rees, Peter Mollee, Jun Yen Ng, et al.
Blood Cancer Journal|March 27, 2024
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?Ing Soo Tiong, Meaghan Wall, Ashish Bajel, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Medical Journal of Australia|October 23, 2021
Progressive multifocal leukoencephalopathy: a complication of prolonged immunosuppression for plasma cell myelomaSophie C Burn, Akash Kalro
Pathology|December 5, 2016
Breakthrough fusariosis presenting initially with pyomyositisAndros Zhu, Swe Htet, Akash Kalro, et al.
Respirology Case Reports|June 7, 2021
Pulmonary AL amyloidosis and multiple myeloma presenting as cough with diffuse pulmonary opacitiesAlan Xu, Emily Lawton, Steven Smith, et al.
Ear, Nose, & Throat Journal|May 14, 2019
Sphenopalatine Artery Ligation for Life-Threatening Epistaxis in a 4-Year-Old Child With Glanzmann ThrombastheniaNayellin Reyes-Chicuellar, Neela Mouli Doddi, Akash Kalro, et al.
Respiratory Medicine Case Reports|December 19, 2018
Pulmonary AL- amyloidosis masquerading as lung malignancy in an Australian Indigenous patient with Sjogren's syndromeSubash Heraganahally, Madeline Digges, Madeleine Haygarth, et al.
Internal Medicine Journal|August 8, 2017
Bisphosphonate guidelines for treatment and prevention of myeloma bone diseaseOi Lin Lee, Noemi Horvath, Cindy Lee, et al.
Internal Medicine Journal|January 12, 2017
Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory GroupDipti Talaulikar, Constantine S Tam, Douglas Joshua, et al.
Bone Marrow Transplantation|April 29, 2021
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograftMatthew J Rees, Peter Mollee, Jun Yen Ng, et al.
Blood Cancer Journal|March 27, 2024
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?Ing Soo Tiong, Meaghan Wall, Ashish Bajel, et al.
Pageof 1